Tema Oncology ETF Rating $37.89 +0.09 (+0.24%) As of 03:59 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Oncology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.CANC Aggregate RatingModerate Buy 2.75Holdings in CANC have an aggregate rating of Moderate Buy based on 405 analyst ratings issued in the past year covering 23 companies (68.7% of the portfolio).CANC Aggregate Price Target$37.89High Prediction$37.89Average Prediction$37.89Low Prediction$37.89Holdings in CANC have an aggregate price target of $37.89 and a range of $37.89 to $37.89 covering 23 companies (68.7% of the portfolio).CANC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Oncology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 CANC Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.29%RVMDRevolution Medicines$147.21-0.5%2.8 of 5 stars3.10$78.94 -46.4%21Upcoming Earnings4.13%RHHBYRoche$50.84+1.1%3.1031 of 5 stars2.45$51.50 1.3%113.97%LLYEli Lilly and Company$989.02+2.2%4.8771 of 5 stars2.87$1,217.59 23.1%30Trending NewsEarnings ReportDividend AnnouncementAnalyst Upgrade3.95%COGTCogent Biosciences$36.97+0.7%2.8911 of 5 stars2.86$43.45 17.5%14News CoveragePositive NewsEarnings Report3.84%IMNMImmunome$23.11-0.9%3.4283 of 5 stars2.91$33.45 44.8%11News CoverageUpcoming EarningsAnalyst Upgrade3.38%BMYBristol Myers Squibb$56.94-0.8%4.7086 of 5 stars2.37$61.31 7.7%19Trending NewsEarnings Report3.27%NUVLNuvalent$101.47-1.1%3.7293 of 5 stars2.88$137.25 35.3%17Upcoming Earnings3.21%MRKMerck & Co., Inc.$113.21+0.1%4.8152 of 5 stars2.68$128.18 13.2%19Trending NewsEarnings Report2.98%BBIOBridgeBio Pharma$68.78-0.3%3.186 of 5 stars2.92$87.71 27.5%25News CoverageUpcoming EarningsInsider Trade2.94%CELCCelcuity$141.69-2.3%1.3594 of 5 stars2.75$134.50 -5.1%12Trending NewsAnalyst Forecast2.89%ERASErasca$9.99-1.5%2.4519 of 5 stars2.50$17.88 78.9%10Upcoming Earnings2.81%GMABGenmab A/S$27.53+1.8%4.7211 of 5 stars2.92$39.07 41.9%12Positive NewsUpcoming EarningsAnalyst Revision2.81%JNJJohnson & Johnson$225.59+0.6%4.921 of 5 stars2.67$252.48 11.9%27Trending News2.62%LEGNLegend Biotech$28.51+7.6%3.3378 of 5 stars2.67$58.31 104.5%15News CoverageUpcoming EarningsHigh Trading Volume2.60%CGONCG Oncology$67.18-0.8%3.3852 of 5 stars2.77$79.55 18.4%13Upcoming Earnings2.57%ABBVAbbVie$206.12-1.0%4.909 of 5 stars2.85$252.90 22.7%26Trending NewsEarnings Report2.53%ZLABZai Lab$20.98-1.1%2.5451 of 5 stars2.63$50.00 138.3%8Upcoming Earnings2.51%EXELExelixis$44.42+0.6%3.3604 of 5 stars2.39$47.00 5.8%23Trending NewsEarnings Report2.19%IDYAIDEAYA Biosciences$28.80-0.3%3.8608 of 5 stars2.82$50.44 75.1%17News CoverageEarnings ReportGap Down2.16%AMGNAmgen$329.59+1.8%4.4701 of 5 stars2.42$357.12 8.4%31Trending NewsEarnings ReportAnalyst Forecast1.94%ONCBeOne Medicines$297.49+0.1%4.4234 of 5 stars2.71$390.58 31.3%14News CoveragePositive NewsUpcoming EarningsAnalyst Forecast1.63%ZYMEZymeworks$26.68-0.4%2.4825 of 5 stars2.92$37.89 42.0%13Upcoming Earnings1.52%SMMTSummit Therapeutics$17.54+3.3%2.4542 of 5 stars2.59$27.58 57.3%17News CoverageEarnings ReportAnalyst Upgrade This page (NASDAQ:CANC) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSell 99% of Your Stocks, Do THIS Instead…Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...The Oxford Club | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Unveils AI Passive Income Stream for Millions of AmericansDuring Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...InvestorPlace | SponsoredInvest in SpaceX Before IPOSpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...NXT Wave Research | SponsoredURGENT: $2 Gold Stock With Major DiscoveryA $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
